GET THE APP

Catalytic activity of N-terminal methionine modification in recombinant streptokinase expressed in E. coli
..

Journal of Bioanalysis & Biomedicine

ISSN: 1948-593X

Open Access

Catalytic activity of N-terminal methionine modification in recombinant streptokinase expressed in E. coli


4th International Conference and Exhibition on Biologics & Biosimilars

October 26-28, 2015 Baltimore, USA

Dinesh Kumar P

Micro Therapeutic Research Labs Pvt. Ltd., India

Posters-Accepted Abstracts: J Bioanal Biomed

Abstract :

Native streptokinase is usually prepared from culture of Streptococcus equisimilis for therapeutic purpose of intravenous thrombolytic agent for the treatment of myocardial infarction. The N-terminal amino acid of native streptokinase starts with Isoleucine (I), Alanine (A) and Glycine (G) and followed by Proline (P) etc. The first of amino acid of Isoleucine is playing an important role for the catalytic activity of streptokinase is binding towards inactive plasminogen to activate plasminogen. The specific activity of native streptokinase is 100000 IU/mg with the initial N- terminal isoleucine amino acid. Despite the recombinant streptokinase of N-terminal amino acid begins with methionine and it is a proteinogenic for E. coli expression. Comparison for specific activity of recombinant streptokinase shows only 85000IU/mg than 100000IU/mg native streptokinase. The reason behind this objective is that there are two forms (Isomers) of streptokinase are expressed in E. coli which was analysed by RP-HPLC and chromogenic assay. We have found that this variation is formed by isomer-1 has 85% of Streptokinase expressed without methionine (85000IU/mg) and Isomer-2 has 15% of streptokinase expressed with methionine (nil activity) in E. coli. This phenomenon is clearly demonstrating that the presence and absence of methionine in isomers are varying the streptokinase activity. Hence the methionine alters the streptokinase catalytic activity and is an important role for both activity and immunogenic. This is the first attempt to explore the methionine variation by our method development on RP-HPLC and chromogenic assay for improving the suppression of risk management of myocardial infarction.

Biography :

Email: dinesh_trk@yahoo.co.in

Google Scholar citation report
Citations: 3099

Journal of Bioanalysis & Biomedicine received 3099 citations as per Google Scholar report

Journal of Bioanalysis & Biomedicine peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward
https://www.olimpbase.org/1937/